CYP2C19Genetic Polymorphism in Saudi Arabians

CYP2C19 and ABCB1gene polymorphisms are differently distributed according to ethnicity in the Brazilian general population

(2011) Paulo CJL Santos et al.   BMC Medical Genetics

Clinically Relevant Genetic Variations in Drug Metabolizing Enzymes

(2011) Navin Pinto et al.   CURRENT DRUG METABOLISM

Distribution of CYP2C19*17 allele and genotypes in an Indian population

(2011) D. Anichavezhi et al.   JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS

Prevalence of CYP2C19 polymorphisms in the Lebanese population

(2011) Isabelle Djaffar Jureidini et al.   MOLECULAR BIOLOGY REPORTS

Genetic polymorphism of CYP2C19 in a Jordanian population: influence of allele frequencies of CYP2C19*1 and CYP2C19*2 on the pharmacokinetic profile of lansoprazole

(2011) Imad Zalloum et al.   MOLECULAR BIOLOGY REPORTS

Ensembl Genomes: an integrative resource for genome-scale data from non-vertebrate species

(2011) Paul J. Kersey et al.   NUCLEIC ACIDS RESEARCH

Cytochrome 2C19*17 Allelic Variant, Platelet Aggregation, Bleeding Events, and Stent Thrombosis in Clopidogrel-Treated Patients With Coronary Stent Placement

(2010) Dirk Sibbing et al.   CIRCULATION

A map of human genome variation from population-scale sequencing

(2010) Richard M. Durbin et al.   NATURE

A method and server for predicting damaging missense mutations

(2010) Ivan A Adzhubei et al.   NATURE METHODS

Characterization of the genetic profile ofCYP2C19in two South African populations

(2010) Britt I Drögemöller et al.   PHARMACOGENOMICS

Identification of New CYP2C19 Variants Exhibiting Decreased Enzyme Activity in the Metabolism of S-Mephenytoin and Omeprazole

(2009) S.-J. Lee et al.   DRUG METABOLISM AND DISPOSITION

Assessment of CYP2C19 genetic polymorphisms in a korean population using a simultaneous multiplex pyrosequencing method to simultaneously detect the CYP2C19*2, CYP2C19*3, and CYP2C19*17 alleles

(2009) K.-A. Kim et al.   JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS

Genetic polymorphism, linkage disequilibrium, haplotype structure and novel allele analysis of CYP2C19 and CYP2D6 in Han Chinese

(2009) Q Zhou et al.   PHARMACOGENOMICS JOURNAL

Limited frequency of the CYP2C19*17 allele and its minor role in a Japanese population

(2008) Katsuyoshi Sugimoto et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

The CYP2C19 ultra-rapid metabolizer genotype influences the pharmacokinetics of voriconazole in healthy male volunteers

(2008) Guo Wang et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Need for reassessment of reportedCYP2C19allele frequencies in various populations in view ofCYP2C19*17discovery: the case of Greece

(2008) Georgia Ragia et al.   PHARMACOGENOMICS